Dr. Aldrovandi is a translational physician-scientist and her expertise and innovative research has far-reaching collaborations. In 2014, Dr. Aldrovandi was part of a consortium that was awarded nearly $21 million by the National Institute of Allergy and Infectious Diseases for studies to advance the prevention and treatment of HIV and its complications for infants, children, adolescents, and pregnant/postpartum women. In addition to pediatric HIV, Dr. Aldrovandi’s research interests include the effects of breast milk on child health, and infections in immunocompromised children. Her laboratory has a broad-based program to investigate the transmission of HIV from mother to child, the pathogenesis of HIV in children and the protective value of breastfeeding. Dr. Aldrovandi received her MD degree from McGill University in Montreal, Canada, where she also did her pediatric residency. She completed her research fellowship in pediatric infectious diseases at UCLA and currently presides as the Chief of the Division of Pediatric Infectious Diseases at UCLA as well.
Dr. Bender is pediatric infectious diseases specialist at Children’s Hospital Los Angeles (CHLA) and Associate Professor of Pediatrics at USC Keck School of Medicine. He completed pediatric residency and pediatric infectious diseases fellowship at the University of Utah. He went on to further pursue training in medical microbiology and completed a fellowship through the Department of Pathology at the University of Utah and ARUP Laboratories. He is one of only a handful of physicians’ board certified in both pediatric infectious diseases and medical microbiology through the American Boards of Pediatrics and Pathology respectfully. His primary research interest currently lies in the infant microbiome and how interactions with indigenous microbial communities may translate to novel preventative and therapeutic approaches to pediatric disease. An active medical educator, he is the assistant program director for the pediatric infectious diseases fellowship program and part of the steering committee for the medical microbiology fellowship program at CHLA. Furthermore, he is the medical director of the Infection Prevention and Control Committee at CHLA and co-director of the Single-cell, Sequencing, and Cytof Core Laboratory at the Saban Research Institute of CHLA.
Blake W. Buchan, PhD, D(ABMM) is Assistant Professor of Pathology at the Medical College of Wisconsin and Associate Director of Microbiology at Wisconsin Diagnostic Laboratories, Milwaukee, WI. He was awarded a PhD in microbiology from the University of Iowa in 2009 and completed postdoctoral training in Clinical Microbiology at the Medical College of Wisconsin and Froedtert Hospital in 2011. Dr. Buchan is a member of several professional societies including ASM and SCACM, and is a member of the editorial board for the Journal of Clinical Microbiology. His interests include MALDI-TOF MS, PCR, and microarray-based diagnostics for the detection of bacterial, viral and fungal pathogens.
Jennifer Dien Bard, Ph.D., D(ABMM), is the Director of the Clinical Microbiology and Virology laboratories at Children’s Hospital Los Angeles (CHLA) and Associate Professor of Clinical Pathology at the University of Southern California, Keck School of Medicine. She is has extensive experience in diagnostic microbiology and her current research interests include the development and utilization of rapid laboratory diagnostics and their subsequent impact on patient management.
Omai Garner is a Health Sciences Assistant Clinical Professor and Section Chief of Clinical Microbiology in the UCLA Health System. He received his PhD from UC San Diego in Biomedical Sciences. He was a Postdoctoral Clinical Microbiology CPEP Fellow in the Department of Pathology at UCLA, and a former McNair Scholar. Dr. Garner is Board Certified by the American Board of Medical Microbiology. Dr. Garner's research focuses on novel Point of Care Devices for infectious disease diagnosis in the developing world. Dr. Garner was always taught that science, at its best, is a collaborative process. "It is collaboration, and not competition, which produces the most significant advances in biomedical research." He also serves as the Chairman of the Board for the Social Justice Learning Institute of Inglewood, California.
Dr. Nicole Green is the Laboratory Director for the Los Angeles County Public Health Laboratories. She received her Bachelor of Science degree with Honors in Biology and a minor in Microbiology from California State University, Los Angeles. Her doctoral degree in Microbiology was awarded from the University of California, Davis. She has worked at a number of institutions including UC Davis, NIAID-NIH Rocky Mountain Laboratories, Baylor College of Medicine, and The Methodist Hospital Research Institute. She completed her fellowship training in public health and clinical microbiology through the UC Berkeley School of Public Health, California Department of Public Health, and San Francisco General Hospital. Notable awards include the Los Angeles County Department of Public Health - Public Health Excellence award for scientific contributions and the Association of Public Health Laboratories Thomas E. Maxon award for education, training, and workforce development. Dr. Green is the President for the California Association of Public Health Laboratory Directors and also the Secretary for Southern California American Society for Microbiology. She is an adjunct assistant professor at the UCLA Fielding School of Public Health and USC Keck School of Medicine. She is passionate about teaching and is committed to workforce development of new public health and clinical microbiology professionals.
Dr. William Lainhart is an Assistant Professor of Pathology at the University of Arizona, and the Medical Director of Clinical and Molecular Microbiology at the Banner University Medical Center - Tucson. Dr. Lainhart received his PhD in Biomedical Sciences from the University at Albany, State University of New York and the Wadsworth Center, New York State Department of Health. After receiving his PhD, Dr. Lainhart worked as a postdoctoral research fellow at the Wadsworth Center in the Clinical Microbiology and Clinical Virology laboratories. Additionally, Dr. Lainhart recently completed a 2-year CPEP-approved Clinical and Public Health Microbiology Fellowship at Washington University School of Medicine in St. Louis.
Amy received her PhD from the Ohio State University and did a post-doctoral Fellowship in Clinical and Public Health Microbiology at UCLA Medical Center. She is a diplomate of the American Board of Microbiology and active in the American Society for Microbiology, ASCP, and AMP. She is currently the Director of Microbiology at Nationwide Children's Hospital in Columbus Ohio and an Associate Professor of Pathology and Pediatrics at The Ohio State University. She is the editor-in-Chief of the Clinical Microbiology Procedures Handbook. Her research interests include new molecular diagnostics and diagnosis of infectious diseases in pediatric populations.
Dr. Massimelli is a microbiologist (BS in Microbiology) and has a PhD in Biology, obtaining both at the National University of Rio Cuarto in Argentina. She did her postdoctoral training in RNA biology and tumor viruses at the National Institutes of Health, National Cancer Institute. She trained as an educator and curriculum designer through several programs, including a mentored Visiting Faculty position at the Claremont colleges, and the American Society for Microbiology Teaching fellows and Biology scholars. She is currently an Assistant Professor of Teaching at UC Irvine. Dr. Massimelli conducts educational research with an emphasis on microbiology curriculum design, curriculum assessment and outreach. She was part of a national team that developed the Microbiology concept inventory (published in 2017). As a faculty heavily invested in data-driven teaching interventions and classroom assessment, Dr. Massimelli has made numerous presentations at local and national STEM education meetings, and has published several articles that discuss and validate active learning tools for the Microbiology classroom.
Dr. McGowin is a Scientific Affairs Manager within Medical Affairs, and covers the Women’s Health and STI portfolio at Roche Diagnostics in the U.S. Chris has a Ph.D. in Pathology from the University of Texas Medical Branch, and prior to joining Roche in 2017, spent fifteen years in academia working on the mechanistic, clinical, and diagnostic aspects of STIs and their impact on Women’s health and HIV transmission.
Dr. Margie Morgan obtained her PhD degree from the University of Oklahoma Health Sciences Center and then completed a postdoctoral fellowship in clinical Microbiology and Immunology at the Mayo Clinic. She is board certified by the American Board of Medical Microbiology in Medical and Public Health Microbiology. Dr. Morgan is the Scientific Director of the Division of Microbiology and a Professor of Pathology and Laboratory Medicine at Cedars-Sinai Medical Center in Los Angeles. She has been at Cedars-Sinai for over 30 years. Her research interests include molecular methods for the detection of blood culture pathogens, antimicrobial stewardship algorithms and outcomes, and Clostridium difficile surveillance and transmission.
Ina Park, MD, MS is an Associate Professor in the Department of Family and Community Medicine at University of California San Francisco School of Medicine, Medical Director of the California Prevention Training Center and a Medical Consultant for the Centers for Disease Control and Prevention (CDC)-Division of STD Prevention. She received her MD from the UCLA School of Medicine and MS in Clinical Research from the University of Minnesota-School of Public Health. Following residency in Family Medicine at Kaiser Permanente, Los Angeles, she completed a fellowship in Sexually Transmitted Diseases at UC San Francisco and the California Department of Public Health. For 10 years she served as the Chief of the Office of Medical and Scientific Affairs for the California Department of Public Health-STD Control Branch. Dr. Park is a co-author of the 2015 CDC STD Treatment Guidelines and the forthcoming CDC Guidelines for the Laboratory Diagnosis of Syphilis. She is also at work on a book about STDs for the lay public entitled Strange Bedfellows: Adventures in sex and its least intended consequences (Macmillan) which is scheduled for publication in the fall of 2019.
Dr. Peter Ruane is a practicing physician with over 30 years of experience. Born and raised in Ireland, he earned his Medical Degree from University College Dublin. Dr. Ruane completed his internal medicine residency at Mayo Clinic (Rochester, Minnesota) before becoming Board Certified in Infectious Diseases during his research and clinical fellowship at the West Los Angeles Veterans Affairs Medical Center. He has twenty-five years of experience diagnosing and treating complex HIV related infections with the best antiviral therapies and is actively engaged in PrEP clinical trials.
Audrey N. Schuetz, MD, MPH, D(ABMM), is an Associate Professor of Laboratory Medicine and Pathology at the Mayo Clinic School of Medicine and Science in Rochester, Minnesota. She received her M.D. and completed Pathology residency and Medical Microbiology fellowship and at Emory University School of Medicine. She is board-certified in Clinical Pathology, Anatomic Pathology and Medical Microbiology through the American Board of Pathology and is board-certified by the American Board of Medical Microbiology. Dr. Schuetz is Director of the Initial Processing and the Media Laboratories and Co-Director of the Bacteriology Laboratory in Division of Clinical Microbiology at Mayo. She is a member of the Expert Panel of Microbiology of the Clinical and Laboratory Standards Institute and is a member of the CLSI Subcommittee on Antimicrobial Susceptibility Testing. Her interests include antimicrobial susceptibility testing, anaerobic bacteriology, and Infectious Diseases Pathology.
Dr. Rosemary She is the Director of Microbiology at the Keck Medical Center of USC in Los Angeles. She is a pathologist subspecialized in medical microbiology, completing her pathology training at ARUP Laboratories/University of Utah Medical Center in 2008. She is currently Associate Professor of Clinical Pathology at the Keck School of Medicine of USC.
Dr. Thomas J. Walsh has dedicated his professional life to infectious diseases supportive care of children and adults with cancer, transplantation, and other immunodeficiencies. Widely recognized as one of the world’s preeminent mycologists, his internationally recognized translational research of invasive mycoses in immunocompromised hosts has revolutionized the field, his teaching and mentoring have created a generation of new scholars, his devoted patient care has directly saved the lives of hundreds immunocompromised children and adults with severe invasive fungal infections worldwide, and his loyal service to ASM has admirably strengthened its mission over three decades. Following graduation with honors from Johns Hopkins University School of Medicine, Dr. Walsh pursued a course of 10 years of post-doctoral training. He then worked for nearly a quarter-century at the National Cancer Institute, where he became Chief of the Immunocompromised Host Section in the Pediatric Oncology Branch. He was subsequently recruited to become Founding Director of the new Transplantation-Oncology infectious Diseases Program of Cornell University Medical Center. During the past 30 years, Dr. Walsh has changed the face of antifungal chemotherapy, laboratory diagnostics, and understanding of innate host defenses in pediatric and adult cancer patients. Through more than 1,000 publications and 98 clinical protocols, Dr. Walsh and his colleagues have methodically investigated the pharmacology, experimental therapeutics, immunopharmacology, pharmacogenomics, metabolomics, and clinical activity of multiple classes of antifungal agents, as well as achieving major advances in cytokine augmentation of host-defenses, and molecular, biochemical and antigenic therapeutic monitoring of life-threatening mycoses. His exhaustive body of laboratory and clinical investigations has become a paradigm for translational research. He cofounded a Consortium that established a historically unprecedented accomplishment through 12 clinical trials of systematically studying the safety, tolerability, and pharmacokinetics of the entire class of systemic antifungal agents used in pediatric oncology and other pediatric immunodeficient patients. This formidable body of research has been accomplished in the setting where Dr. Walsh also has serves as an international resource for treatment of seriously ill children and adults with life-threatening mycoses. He has also been a mentor and supporter to more than 180 students, fellows, and junior faculty members throughout the United States and abroad; many are now full Professors of Pediatrics, Medicine, Microbiology, and/or Pharmacology. With faculty appointments in three major medical institutions, Dr Walsh has trained more than 6,000 medical students, graduate students, undergraduates, pharmacy students, and laboratory technologists with core lectures in the biology, pathogenesis, host defenses epidemiology, clinical manifestations, laboratory diagnosis, treatment, and prevention of medically important fungal infections. He also has provided outstanding leadership, innovation, and loyalty over his 34 years as a member of the ASM, in many capacities. SCASM is delighted and honored for Dr. Walsh to serve as the American Society of Microbiology Distinguished Lecturer and Waksman Foundation Lecturer for its 2018 Meeting.
Dr. Katrine Whiteson is an Assistant Professor at University of California Irvine and the Associate Director of the recently launched UCI Microbiome Initiative. She studied Biochemistry at UC Berkeley (BA, 2000) and University of Chicago (PhD, 2007). She first had the opportunity to study human-associated microbes at the University of Geneva Hospitals in 2008. Dr. Whiteson focused on the oral microbial communities of healthy Europeans, and malnourished children in Niger who develop a devastating facial gangrene known as noma. In 2011 she moved to Prof. Forest Rohwer’s lab at San Diego State, where she undertook breath and sputum metabolite analysis to better understand the activity of Cystic Fibrosis patient microbial communities. Combining sequencing and metabolomics data is a powerful approach that Dr. Whiteson has continued to employ since starting a lab at UCI in 2014. More information can be found here: http://faculty.sites.uci.edu/whitesonlab/